Critical Outcome Technologies Inc. Stock Toronto S.E.
Equities
COT
CA22675B1031
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.21M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.48M | Net income 2019 | -2M -2.74M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.83K | Net cash position 2019 | 24.64K 33.78K | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 14-12-31 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 17-06-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-06-30 | |
John C. Drake
CHM | Chairman | - | 07-02-19 |
Alison D. Silva
PSD | President | 46 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+2.49% | 96.73B | |
-0.38% | 21.31B | |
-16.61% | 21.21B | |
-5.34% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- COTQF Stock
- COT Stock